Core Points - The stock price of Yueshin Health (002162) closed at 4.4 yuan, down 2.65% as of July 29, 2025, with a turnover rate of 7.84% and a trading volume of 720,200 hands, amounting to 325 million yuan in transaction value [1] - The latest financial report for Yueshin Health shows total operating revenue of 196 million yuan, a year-on-year decrease of 11.46%, while net profit attributable to shareholders was 8.33 million yuan, an increase of 36.02% [1] - The company has a current ratio of 0.853, a quick ratio of 0.641, and a debt-to-asset ratio of 59.54% [1] Financial Performance - Total operating revenue for Q1 2025 was 196 million yuan, down 11.46% year-on-year [1] - Net profit attributable to shareholders was 8.33 million yuan, up 36.02% year-on-year [1] - Non-recurring net profit was 12.11 million yuan, an increase of 19.56% year-on-year [1] Capital Flow - Main capital outflow today was 14.65 million yuan, accounting for 4.51% of the transaction value [1] - Large orders saw a net outflow of 10.50 million yuan, representing 3.23% of the transaction value [1] - Small orders experienced a net outflow of 8.66 million yuan, which is 2.67% of the transaction value [1] Company Overview - Yueshin Health Group was established in 1993 and is located in Shanghai, primarily engaged in the non-metallic mineral products industry [2] - The company has made investments in 17 enterprises and participated in 80 bidding projects [2] - It holds 114 trademark registrations and 435 patents, along with 43 administrative licenses [2]
悦心健康(002162)7月29日主力资金净流出1464.70万元